Förmaksflimmer - ny kunskap ger nya behandlingsmöjligheter

Bertil Olsson, Jonas Carlson, Tomas Fahraeus, Anders P Hansson, Eva Hertervig, Max Ingemansson, Ole Kongstad Rasmussen, Carl-Johan Lindholm, Carl Meurling, Pyotr Platonov, Anders Roijer, Shiwen Yuan

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Atrial fibrillation (AF) is the most common cardiac arrhythmia prompting treatment. Advances in our knowledge of the pathophysiology of AF provide the basis for new and improved treatment modalities. Thus, focal excitation and localised impulse conduction defects are possible trigger factors which can be counteracted by focal ablation and pacing synchronisation, respectively. Perpetuation of AF, caused by continuous multisite re-entry, is promoted by successive shortening of repolarisation. Internal defibrillation and anatomical limitation of re-entry are treatments that counteract perpetuation of the arrhythmia. Current knowledge of AF and the application of new treatments are discussed by the Lund AF research group.
Bidragets titel på inmatningsspråkAtrial fibrillation--new knowledge yields new therapeutic possibilities
Originalspråksvenska
Sidor (från-till)3796-3803
TidskriftLäkartidningen
Volym96
Utgåva36
StatusPublished - 1999

Ämnesklassifikation (UKÄ)

  • Kardiologi

Fingeravtryck

Utforska forskningsämnen för ”Förmaksflimmer - ny kunskap ger nya behandlingsmöjligheter”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här